Phillygenin Inhibits TGF-β1-induced Hepatic Stellate Cell Activation and Inflammation: Regulation of the Bax/Bcl-2 and Wnt/β-catenin Pathways.

[1]  Cheng Wang,et al.  A comprehensive review on pharmacological, toxicity, and pharmacokinetic properties of phillygenin: Current landscape and future perspectives. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  S. Friedman,et al.  Friend or foe? The elusive role of hepatic stellate cells in liver cancer , 2023, Nature Reviews Gastroenterology & Hepatology.

[3]  F. Tacke,et al.  Hepatic inflammatory responses in liver fibrosis , 2023, Nature Reviews Gastroenterology & Hepatology.

[4]  Cheng Wang,et al.  Phillygenin Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis: Suppression of Inflammation and Wnt/β-Catenin Signaling Pathway , 2023, Inflammation.

[5]  Cheng Wang,et al.  Phillygenin inhibited M1 macrophage polarization and reduced hepatic stellate cell activation by inhibiting macrophage exosomal miR-125b-5p. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  B. Hinz,et al.  The Role of Myofibroblasts in Physiological and Pathological Tissue Repair. , 2022, Cold Spring Harbor perspectives in biology.

[7]  Jizhi Jiang,et al.  Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[8]  D. Green.  The Mitochondrial Pathway of Apoptosis Part II: The BCL-2 Protein Family. , 2022, Cold Spring Harbor perspectives in biology.

[9]  Cheng Wang,et al.  Hepatoprotective effect of phillygenin on carbon tetrachloride-induced liver fibrosis and its effects on short chain fatty acid and bile acid metabolism. , 2022, Journal of ethnopharmacology.

[10]  Zhaoguo Liu,et al.  Rat bone marrow mesenchymal stem cells (BMSCs) inhibit liver fibrosis by activating GSK3β and inhibiting the Wnt3a/β-catenin pathway , 2022, Infectious agents and cancer.

[11]  Qian-yun Sun,et al.  Dietary phillygenin supplementation ameliorates aflatoxin B1-induced oxidative stress, inflammation, and apoptosis in chicken liver. , 2022, Ecotoxicology and environmental safety.

[12]  Jinmao Liao,et al.  The Mouse Anxa6/miR-9-5p/Anxa2 Axis Modulates TGF-β1-induced Mouse Hepatic Stellate Cell (mHSC) Activation and CCl4-caused Liver Fibrosis. , 2022, Toxicology letters.

[13]  Gang Yin,et al.  Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities , 2022, Signal Transduction and Targeted Therapy.

[14]  Hammad Ahmed,et al.  TGF-β1 signaling can worsen NAFLD with liver fibrosis backdrop. , 2021, Experimental and molecular pathology.

[15]  Cheng Wang,et al.  Phillygenin Attenuates Carbon Tetrachloride-Induced Liver Fibrosis via Modulating Inflammation and Gut Microbiota , 2021, Frontiers in Pharmacology.

[16]  E. Harris,et al.  Pathophysiological Communication between Hepatocytes and Non-Parenchymal Cells in Liver Injury from NAFLD to Liver Fibrosis. , 2021, Advanced drug delivery reviews.

[17]  D. Brenner,et al.  Molecular and cellular mechanisms of liver fibrosis and its regression , 2020, Nature Reviews Gastroenterology & Hepatology.

[18]  D. Fliser,et al.  WNT–β-catenin signalling — a versatile player in kidney injury and repair , 2020, Nature Reviews Nephrology.

[19]  Yongfang Jiang,et al.  CAT1 silencing inhibits TGF-β1-induced mouse hepatic stellate cell activation in vitro and hepatic fibrosis in vivo. , 2020, Cytokine.

[20]  Hanlin Xu,et al.  Galangin Reverses Hepatic Fibrosis by Inducing HSCs Apoptosis via the PI3K/Akt, Bax/Bcl-2, and Wnt/β-catenin Pathway in LX-2 Cells. , 2020, Biological & pharmaceutical bulletin.

[21]  Naihua Hu,et al.  Forsythiae Fructuse water extract attenuates liver fibrosis via TLR4/MyD88/NF-κB and TGF-β/smads signaling pathways. , 2020, Journal of ethnopharmacology.

[22]  K. Mekeel,et al.  Liver fibrosis: Pathophysiology and clinical implications , 2020, Wiley interdisciplinary reviews. Systems biology and medicine.

[23]  N. Vaziri,et al.  Wnt signaling pathway in aging-related tissue fibrosis and therapies , 2020, Ageing Research Reviews.

[24]  Naihua Hu,et al.  Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway. , 2020, Journal of ethnopharmacology.

[25]  B. Hinz,et al.  Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases , 2019, Nature Reviews Rheumatology.

[26]  M. Pinzani,et al.  Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. , 2019, Molecular aspects of medicine.

[27]  Guimin Zhang,et al.  Phillygenin exhibits anti-inflammatory activity through modulating multiple cellular behaviors of mouse lymphocytes , 2019, Immunopharmacology and immunotoxicology.

[28]  J. Marin,et al.  Wnt–β-catenin signalling in liver development, health and disease , 2018, Nature Reviews Gastroenterology & Hepatology.

[29]  Y. Osawa,et al.  Wnt/β-Catenin Signaling as a Potential Target for the Treatment of Liver Cirrhosis Using Antifibrotic Drugs , 2018, International journal of molecular sciences.

[30]  Longjiang Yu,et al.  Evaluation of the Pharmacokinetics and Hepatoprotective Effects of Phillygenin in Mouse , 2018, BioMed research international.

[31]  Xiao-ming Meng,et al.  Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/&bgr;‐catenin signaling pathway, c‐Myc and cyclin D1 , 2018, International immunopharmacology.

[32]  D. Sheppard,et al.  TGF-β1 Signaling and Tissue Fibrosis. , 2018, Cold Spring Harbor perspectives in biology.

[33]  S. Friedman,et al.  Hepatic stellate cells as key target in liver fibrosis. , 2017, Advanced drug delivery reviews.

[34]  F. Edlich.  BCL-2 proteins and apoptosis: Recent insights and unknowns. , 2017, Biochemical and biophysical research communications.

[35]  R. Nusse,et al.  Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities , 2017, Cell.

[36]  S. Friedman,et al.  Mechanisms of hepatic stellate cell activation , 2017, Nature Reviews Gastroenterology &Hepatology.

[37]  S. Friedman,et al.  β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation. , 2014, Cancer letters.

[38]  Y. Huang,et al.  Wnt signaling in liver fibrosis: progress, challenges and potential directions. , 2013, Biochimie.

[39]  J. Distler,et al.  Canonical Wnt signalling as a key regulator of fibrogenesis – implications for targeted therapies? , 2013, Experimental dermatology.

[40]  Martina Schneider,et al.  Loss of Xenopus cadherin-11 leads to increased Wnt/β-catenin signaling and up-regulation of target genes c-myc and cyclin D1 in neural crest. , 2013, Developmental biology.

[41]  Christopher J. Parsons,et al.  Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. , 2006, Journal of hepatology.

[42]  F. Marra,et al.  Cytokine Receptors and Signaling in Hepatic Stellate Cells , 2001, Seminars in liver disease.

[43]  Fuyou Liu,et al.  Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. , 2012, Physiological research.

[44]  S. Friedman.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.

[45]  J. Lieberman,et al.  Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. , 2004, The American journal of psychiatry.